SB 253 — Granite Record https://graniterecord.org/bill/2025/sb253.html relative to participation in the federal 340B Drug Pricing Program. en-us Fri, 04 Sep 2026 00:00:00 +0000 SB 253 — Committee Report: Inexpedient to Legislate, 03/06/2025, Vote 3-2https://graniterecord.org/bill/2025/sb253.htmlSB253:2025-03-06:committee-report-inexpedient-to-legislatThu, 06 Mar 2025 00:00:00 +0000relative to participation in the federal 340B Drug Pricing Program. Committee Report: Inexpedient to Legislate, 03/06/2025, Vote 3-2 Status: Pending action in the other chamber SB 253 — Inexpedient to Legislate, MA, VV = =; 03/06/2025https://graniterecord.org/bill/2025/sb253.htmlSB253:2025-03-06:inexpedient-to-legislate-ma-vv-03-06-202Thu, 06 Mar 2025 00:00:00 +0000relative to participation in the federal 340B Drug Pricing Program. Inexpedient to Legislate, MA, VV = =; 03/06/2025 Status: Pending action in the other chamber SB 253 — Hearing: 02/19/2025, Room 100, SH, 09:45 amhttps://graniterecord.org/bill/2025/sb253.htmlSB253:2025-02-19:hearing-02-19-2025-room-100-sh-09-45-amWed, 19 Feb 2025 00:00:00 +0000relative to participation in the federal 340B Drug Pricing Program. Hearing: 02/19/2025, Room 100, SH, 09:45 am Status: Pending action in the other chamber SB 253 — Introduced 01/09/2025 and Referred to Health and Human Serviceshttps://graniterecord.org/bill/2025/sb253.htmlSB253:2025-01-09:introduced-01-09-2025-and-referred-to-heThu, 09 Jan 2025 00:00:00 +0000relative to participation in the federal 340B Drug Pricing Program. Introduced 01/09/2025 and Referred to Health and Human Services Status: Pending action in the other chamber